Affiliation:
1. Department of Diagnostic Radiology American University of Beirut Medical Center Beirut Lebanon
2. Department of Obstetrics and Gynecology/Division of Gynecologic Oncology The University of Chicago Chicago Illinois USA
3. Ministry of Public Health‐Epidemiological Surveillance Program Beirut Lebanon
4. Department of Radiology/Division of Abdominal Imaging Massachusetts General Hospital Boston Massachusetts USA
5. The Russel H. Morgan Department of Radiology and Radiological Science The Johns Hopkins School of Medicine Baltimore Maryland USA
Abstract
AbstractIntroductionBreast magnetic resonance imaging (MRI) is increasingly being used for staging of patients with breast cancer due to its high sensitivity in detecting additional cancers (ACs). However, the clinical impact of diagnosing and treating these cancers remains unclear.MethodsA retrospective study was undertaken of patients with newly diagnosed breast cancer who underwent staging MRI at The American University of Beirut Medical Centre (AUBMC) between 2012 and 2020. Pathology reports and breast MRI examinations were reviewed. Eighteen breast cancer patients with 19 pathology‐proven index cancers (ICs) and 19 pathology‐proven MRI‐detected ACs were included. Chi‐square and Fisher's exact tests for categorical variables and Wilcoxon signed rank test for numerical variables were used to compare ICs to ACs.ResultsThe ICs consisted of four ductal carcinoma in situ (DCIS), 13 invasive ductal carcinomas (IDC), of which five with associated DCIS, and two invasive lobular carcinomas, (ILC) of which one with associated DCIS. ACs comprised 12 DCIS, five IDC, two with associated DCIS and two ILC, one with associated DCIS. Interval cancers were more frequently invasive whereas ACs were more frequently in situ (P = 0.021). ACs were more frequently nuclear grade 2 (P = 0.009). There was no statistically significant difference between ICs and ACs in lesion type (P = 0.062), shape (P = 0.073), initial enhancement (P = 1), delayed enhancement (P = 0.732), hormonal receptor profile (P = 0.68) and Ki67 (P = 0.388). Among ACs, ten (53%) were larger than 10 mm of which five (26%) were invasive cancers, and five (26%) were larger than the ICs.ConclusionsACs detected by breast MRI were more likely to be in situ and to show a nuclear grade 2. Although not reaching statistical significance, some ACs tend to be clinically significant by their type, size or nuclear grade. The impact on clinical management remains to be determined.
Subject
Radiology, Nuclear Medicine and imaging,Radiological and Ultrasound Technology